This company seems to have been delisted
Reason: Delisted by Nasdaq
Last recorded trade on: February 22, 2023
Source: https://www.globenewswire.com/en/news-release/2022/12/28/2580400/6948/en/Delisting-of-Securities-of-Tuscan-Holdings-Corp-II-Clovis-Oncology-Inc-ZyVersa-Therapeutics-Inc-Otonomy-Inc-and-Forward-Pharma-A-S-from-The-Nasdaq-Stock-Market.html
Reason: Delisted by Nasdaq
Last recorded trade on: February 22, 2023
Source: https://www.globenewswire.com/en/news-release/2022/12/28/2580400/6948/en/Delisting-of-Securities-of-Tuscan-Holdings-Corp-II-Clovis-Oncology-Inc-ZyVersa-Therapeutics-Inc-Otonomy-Inc-and-Forward-Pharma-A-S-from-The-Nasdaq-Stock-Market.html
Clovis Oncology
CLVS
$0.13
Share price
0.00%
Change (1 day)
-94.90%
Change (1 year)
Categories
EPS for Clovis Oncology (CLVS)
EPS in 2022 (TTM): -$2.69
According to Clovis Oncology's latest financial reports the company's current EPS (TTM) is -$3.01. In 2012 the company made an earnings per share (EPS) of -$4.75.
EPS history for Clovis Oncology from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -$2.69 | |
| 2012 | -$4.75 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | $1.24 | -141.20% | 🇺🇸 USA |
 | $3.16 | -205.03% | 🇬🇧 UK |
 | $2.96 | -198.41% | 🇺🇸 USA |
 | $22.40 | -845.25% | 🇺🇸 USA |
 | $5.85 | -294.74% | 🇺🇸 USA |
 | $8.63 | -387.26% | 🇺🇸 USA |